Case Study: Recursion Pharmaceuticals accelerates genetic disease research with Splunk Enterprise

Recursion Pharmaceuticals gains value in 3 days with Splunk

Recursion Pharmaceuticals, a biotech company, faced the challenge of managing enormous volumes of data from automated laboratory instruments as it scaled its mission to discover treatments for 100 genetic diseases. The rapid growth and massive data generation, including 700,000 TIFF files per week, required an extremely scalable solution for operational visibility that could serve diverse users from scientists to executives.

By implementing Splunk Enterprise, Recursion gained a robust data management and observability platform. The solution integrated with their machine learning systems, providing real-time insights into laboratory processes and instrument performance. As a result, Splunk delivered time to value in just three days, enabled substantial cost savings compared to specialized software, and became a critical requirement for managing their breakneck operational scale.

Recursion Pharmaceuticals